Satish Mehta CEO of Emcure Pharmaceuticals and a Drug Price-Fixing Scandal

The Billionaire And The Drug Price-Fixing Scandal. Forbes article

Satish Mehta founded Emcure Pharmaceuticals in 1981. In 2011 Emcure bought U.S. based Heritage Pharmaceuticals founded by Jeffrey Glazer. In 2016 Heritage had U.S. sales of $265 million, 40% of Emcure's total sales.

An article in Forbes, by Nathan Vardi and Nazneen Karmali April 25, 2017, says that, "In September 2015, Satish Mehta, the billionaire chief executive of the Indian drug company Emcure Pharmaceuticals, wrote an effusive email congratulating Jeffrey Glazer, the CEO of his U.S. crown jewel, Heritage Pharmaceuticals, on a job well done. "In a short span of 4.5 years, you have taken Heritage to another level," Mehta wrote, adding that he considered Glazer to be "an integral part of our family."

In January this year, the article continues, "Glazer pleaded guilty to violating U.S. antitrust law by conspiring with manufacturers to fix the prices of generic drugs. Glazer is now cooperating with federal prosecutors--and Mehta appears to be the next target in the politically charged war against price gouging."


To get the full article go to: Billionaire-and-the-drug-price-fixing-scandal, Forbes